In the pharmaceutical industry, bacteria are used to produce antibiotics, vaccines and medically useful enzymes. The biotechnology industry uses bacterial cells for the production of biological substances that are useful to human existence, including fuels, foods, medicines, hormones, enzymes, proteins and nucleic acids, resulting in the development of human hormones such as insulin, enzymes such as streptokinase, and human proteins such as interferon and tumor necrosis factor. These products are used for the treatment of a various medical conditions and diseases, including diabetes, heart attack, tuberculosis, AIDS and SLE (lupus).
Starter cultures are derived from undefined, empirically produced species to attain an end-product with predictable and reproducible quality and quantity characteristics. The production of starter cultures can be divided into two sections.
After fermentation, the bacteria must be processed and separated from the fermentation solution, comprising the cultured micro-organisms and the remainder of the nutrient solution. First, the bacteria are separated from the liquid phase and concentrated: nozzle and self-cleaning steam-sterilizable disc separators are available for this step of the process.
The concentrated culture is then transferred to a freeze dryer (lyophilizer) and dried. Finally, the cultures are packaged under airtight conditions and stored at low temperatures.
The careful treatment of the active culture, sterility and high separation efficiencies are prerequisites for the economical, reliable and efficient processing of bacterial starter cultures. As such, separators from GEA are equipped with hydrohermetic product feed systems that minimize the shear forces experienced when the product enters the bowl, which maintains the viability of the cells.
Showing 4 of 25
Combining process monitoring using online analyzers, together with solid process engineering principles and advanced process modelling techniques will enable processes to be actively controlled in order to compensate for input variations.
Aseptic valves face exceptionally high demands within UltraClean and Aseptic processes. You can be assured that they all provide highest quality in terms of hygienic design and sustainability.
Aseptic back-pressure valves are used to regulate a pre-defined pressure in UltraClean and Aseptic processing plants.
GEA separators are designed for liquid-based applications. Using centrifugal force, they are used for separating suspensions consisting of two or more phases of different densities, i.e. they can be used for liquid-liquid separation, for liquid-liquid-solid separation or for liquid-solid separation. They are equally as effective at separating liq...
GEA is one of the world’s largest systems suppliers for the food, beverage and pharmaceutical sectors. Our portfolio includes machinery and plants as well as advanced process technology, components and comprehensive services. Used across diverse industries, they enhance the sustainability and efficiency of production processes globally.
GEA is listed in the German MDAX and the STOXX® Europe 600 Index and is also among the companies comprising the DAX 50 ESG and MSCI Global Sustainability Indices.
© GEA Group Aktiengesellschaft 2024Cookie settings